Blood cancer drug safety checked in small Follow-Up study
NCT ID NCT02494258
First seen Apr 04, 2026 · Last updated May 01, 2026 · Updated 3 times
Summary
This study looked at the long-term safety of an oral drug called azacitidine in people with blood cancers. Only 5 people who had already taken the drug in earlier studies took part. The main goal was to track any side effects that happened during the extended treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Local Institution - 101
Gainesville, Florida, 32610-0277, United States
-
Local Institution - 102
Houston, Texas, 77030, United States
-
Local Institution - 103
Baltimore, Maryland, 21231, United States
-
Manchester Royal Infirmary
Manchester, M13 9WL, United Kingdom
Conditions
Explore the condition pages connected to this study.